Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 97938

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
September 23, 2025
Product types
Drug
Classifications
Class II
Statuses
Ongoing
Recalling firm wording
Park Avenue Compounding

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.

D-0178-2026
Recall number
D-0178-2026
Initiated
September 23, 2025
Classification
Class II
Status
Ongoing
Recalling firm
Park Avenue Compounding
Quantity
189 bags

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Code information

Lot # 20250507-01D93C, Exp Date: 11-04-2025

Distribution pattern

Distributed in Missouri